- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04850391
Interaction of Sleep, Diurnal Eating Pattern, Gut Microbiota, and Obesity (ObeApp)
December 19, 2025 updated by: Tarja Saaresranta, Turku University Hospital
The goals of the proposed study are 1) to provide scientific basis for the relationship between subjective sleep quality, diurnal eating pattern, gut microbiome, and obesity, 2) to develop and test a pragmatic, cost-effective new tool to advance lifestyle changes using E-health approach, and 3) to compare differences in subjective sleep quality, diurnal eating pattern and gut microbiome at baseline 4) to compare changes induced by the E-health intervention among the three study groups and participants with different work schedules.
Study Overview
Detailed Description
The data are fragmented and studies are focusing on interactions of sleep and obesity, eating pattern and obesity, or gut microbiota and obesity, but not the cross-talk of all these factors in the same individual or population.
Therefore, we need a multifactorial approach to get a more deep insight on the obesity and weight regulation.
Further, novel cost-effective tools to advance lifestyle changes are needed.
Emerging evidence suggests that novel countermeasures, such as modulation of the timing of food intake, may be effective strategies in weight control and prevention of obesity.
The goals of the proposed study are 1) to provide scientific basis for the relationship between subjective sleep quality, diurnal eating pattern, gut microbiome, and obesity, 2) to develop and test a pragmatic, cost-effective new tool to advance lifestyle changes using E-health approach, and 3) to compare differences in subjective sleep quality, diurnal eating pattern and gut microbiome at baseline 4) to compare changes induced by the E-health intervention among the three study groups and participants with different work schedules.
Study Type
Interventional
Enrollment (Actual)
133
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Turku, Finland, 20521
- Turku University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Community dwelling 18 - 65 year old adults
- BMI 18.5 - 30 kg/m2 (n = 40, M:F = 1:1)
- BMI > 30 kg/m2 (n = 40, M:F = 1:1)
- OSAS patients with BMI > 30 kg/m2 using nasal continuous positive airway pressure (CPAP) treatment on an average > 4 h/d (n = 40, M:F = 1:1).
Exclusion Criteria:
- Antimicrobial treatment within 3 months prior the baseline visit
- Inflammatory bowel diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Lean-overweight
BMI 18.5 - 30 kg/m2
|
To compare changes induced by the movile app intervention among the three study groups
|
|
Active Comparator: Obese
BMI > 30 kg/m2
|
To compare changes induced by the movile app intervention among the three study groups
|
|
Active Comparator: Obese OSA
OSAS patients with BMI > 30 kg/m2
|
To compare changes induced by the movile app intervention among the three study groups
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: 2 years
|
Changes in weight
|
2 years
|
|
Waist/Hip ratio
Time Frame: 2 years
|
Changes in Waist/Hip ratio
|
2 years
|
|
Change in Blood Pressure
Time Frame: 2 years
|
Change in Blood Pressure
|
2 years
|
|
GHbA1c
Time Frame: 2 years
|
Change in GHbA1c
|
2 years
|
|
Gut microbiota
Time Frame: 2 years
|
Changes in gut microbiota (species, proportions of different species)
|
2 years
|
|
Timing of eating
Time Frame: 2 years
|
Change in timing of eating
|
2 years
|
|
Subjective sleep quality (Pittsburg Sleep Quality Index)
Time Frame: 2 years
|
Changes in subjective sleep quality
|
2 years
|
|
Excessive daytime sleepiness (Epworth Sleepiness Scale)
Time Frame: 2 years
|
Change in excessive daytime sleepiness
|
2 years
|
|
Mood (DEPS questionnaire)
Time Frame: 2 years
|
Changes in mood
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tarja Saaresranta, MD, PhD, Turku University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2021
Primary Completion (Actual)
October 21, 2024
Study Completion (Actual)
October 21, 2024
Study Registration Dates
First Submitted
April 9, 2021
First Submitted That Met QC Criteria
April 14, 2021
First Posted (Actual)
April 20, 2021
Study Record Updates
Last Update Posted (Actual)
December 29, 2025
Last Update Submitted That Met QC Criteria
December 19, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ObeApp
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.